{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:36:20Z","timestamp":1790674580134,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1-3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ejphar.2013.03.042","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T02:22:27Z","timestamp":1365042147000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Synergistical neuroprotection of rofecoxib and statins against malonic acid induced Huntington's disease like symptoms and related cognitive dysfunction in rats"],"prefix":"10.1016","volume":"709","author":[{"given":"Anil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendriya","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikesh","family":"Kalonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.03.042_bib1","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","article-title":"Huntingtin aggregation and toxicity in Huntington's disease","volume":"361","author":"Bates","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2013.03.042_bib2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","article-title":"Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease","volume":"73","author":"Berman","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2013.03.042_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1358\/dnp.2000.13.9.660938","article-title":"Defining the role of COX-2 inhibitors in inflammatory and other diseases","volume":"13","author":"Botting","year":"2000","journal-title":"Drugs News Perspect."},{"key":"10.1016\/j.ejphar.2013.03.042_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainres.2007.07.067","article-title":"Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta","volume":"1175","author":"Boyd","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2013.03.042_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/cne.903550208","article-title":"Characterization of inducible cyclooxygenase in rat brain","volume":"355","author":"Breder","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.freeradbiomed.2010.12.026","article-title":"Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease","volume":"50","author":"Broom","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2013.03.042_bib7","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1523\/JNEUROSCI.21-14-05110.2001","article-title":"Inhibition of mitochondrial complex \u0399\u0399 induces a long-term potentiation of NMDA mediated synaptic excitation in the striatum requiring endogenous dopamine","volume":"21","author":"Calabresi","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.03.042_bib8","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic drugs: cloning, structure and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"Proct. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2013.03.042_bib9","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","article-title":"Nonsteroidal anti-inflammatory drug use and the risk for Parkinson\u2019s disease","volume":"58","author":"Chen","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(97)00158-7","article-title":"Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of anti-atherosclerotic effects of vitamin E, lovastatin and amlodipine","volume":"30","author":"Chen","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0165-0173(00)00039-4","article-title":"Chemical anatomy of basal interneurons in normal individuals and in patients with Huntington\u2019s disease","volume":"34","author":"Cicchetti","year":"2000","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2013.03.042_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1006\/exnr.2002.7933","article-title":"Mice over expressing 70-kDa heat shock protein show increased resistance to malonate and 3-nitropropionic acid","volume":"176","author":"Dedeoglu","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/path.1320","article-title":"Cholesterol storage and tau pathology in Niemann-Pick type C disease in the brain","volume":"200","author":"Distl","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1471-4159.2010.06912.x","article-title":"Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease","volume":"115","author":"del Toro","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2013.03.042_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2013.03.042_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.arcmed.2007.11.011","article-title":"Excitotoxic neuronal death and the pathogenesis of Huntington's disease","volume":"39","author":"Estrada Sanchez","year":"2008","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ejphar.2013.03.042_bib18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1046\/j.1471-4159.1999.0731329.x","article-title":"Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation","volume":"73","author":"Ferger","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2013.03.042_bib19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2006.10.004","article-title":"Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment","volume":"25","author":"Franke","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2013.03.042_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/01480545.2011.589850","article-title":"Effect of nonselective and selective COX-2 inhibitors on memory dysfunction, glutathione system, and tumor necrosis factor alpha level against cerebral ischemia reperfusion injury","volume":"35","author":"Gaur","year":"2012","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10787-010-0068-y","article-title":"Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction","volume":"19","author":"Gaur","year":"2011","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2013.03.042_bib22","first-page":"664","article-title":"Statins: the drugs for the 21st century","volume":"110","author":"Ginter","year":"2009","journal-title":"Bratisl. Lek. Listy."},{"key":"10.1016\/j.ejphar.2013.03.042_bib23","first-page":"332","article-title":"Analysis of nitrate, nitrite, and 15[N] nitrate in biological fluids","volume":"44","author":"Green","year":"1982","journal-title":"Ann. Biochem."},{"key":"10.1016\/j.ejphar.2013.03.042_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pbb.2009.07.018","article-title":"Protective effect of cyclooxygenase (COX)-inhibitors against drug induced catatonia and MPTP-induced striatal lesion in rats","volume":"94","author":"Gupta","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2013.03.042_bib25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1517\/17425255.4.10.1265","article-title":"Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment","volume":"4","author":"Harry","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.64020919.x","article-title":"Enzymatic oxidation of dopamine: The role of prostaglandin H synthase","volume":"64","author":"Hastings","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2013.03.042_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejpain.2008.06.011","article-title":"Differences in the sensitivity of behavioral measures of pain to the selectivity of cyclo-oxygenase inhibitors","volume":"13","author":"Huntjens","year":"2009","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2013.03.042_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12640-012-9315-x","article-title":"Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington's disease-like symptoms in rats","volume":"22","author":"Kalonia","year":"2012","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2013.03.042_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbr.2010.07.040","article-title":"Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats","volume":"216","author":"Kalonia","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2013.03.042_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainres.2010.11.060","article-title":"Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats","volume":"1372","author":"Kalonia","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2013.03.042_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuro.2009.12.008","article-title":"Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats","volume":"31","author":"Kalonia","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2013.03.042_bib33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2010.02.031","article-title":"Targetting oxidative stress attenuates malonoic acid induced Huntington like behavioural and mitochondrial alterations in rats","volume":"634","author":"Kalonia","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10787-009-0012-1","article-title":"Effect of caffeic acid and rofecoxib and their combination against intrastriatal quinolinic acid induced oxidative damage, mitochondrial and histological alterations in rats","volume":"17","author":"Kalonia","year":"2009","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2013.03.042_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7748\/ns2004.04.18.32.45.c3596","article-title":"Huntington's disease","volume":"18","author":"Kent","year":"2004","journal-title":"Nurs. Stand."},{"key":"10.1016\/j.ejphar.2013.03.042_bib36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0076-6879(67)10061-X","article-title":"Preparation of succinate dehydrogenase and reconstitution of succinate oxidase","volume":"10","author":"King","year":"1967","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0076-6879(67)10055-4","article-title":"Preparations and properties of soluble NADH dehydrogenases from cardiac muscle","volume":"10","author":"King","year":"1967","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.20-01-00001.2000","article-title":"Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"20","author":"Klivenyi","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.03.042_bib39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pbb.2012.07.015","article-title":"Montelukast potentiates the protective effect of rofecoxib against kainic acid-induced cognitive dysfunction in rats","volume":"103","author":"Kumar","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2013.03.042_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejphar.2006.08.076","article-title":"Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats","volume":"551","author":"Kumar","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2012.06.050","article-title":"Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms","volume":"1471","author":"Kumar","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2013.03.042_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1472-8206.2007.00485.x","article-title":"Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms","volume":"21","author":"Kumar","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib44","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/nn1988","article-title":"Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease","volume":"10","author":"Lobsinger","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2013.03.042_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with Folin-Phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2013.03.042_bib46","series-title":"Methods of Enzyme Analysis","first-page":"885","article-title":"Catalase","author":"Luck","year":"1971"},{"key":"10.1016\/j.ejphar.2013.03.042_bib47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1523\/JNEUROSCI.18-01-00156.1998","article-title":"Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington\u2019s disease","volume":"18","author":"Matthews","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.03.042_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Development of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2013.03.042_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejphar.2013.03.042_bib50","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1046\/j.1471-4159.2000.0741656.x","article-title":"Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures","volume":"74","author":"Moy","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2013.03.042_bib51","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2008.10.023","article-title":"Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease","volume":"448","author":"Patassini","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2013.03.042_bib52","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.ejphar.2013.03.042_bib53","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbr.2008.11.037","article-title":"Targeting oxidative\/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease","volume":"199","author":"Perez-De La Cruz","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2013.03.042_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington's disease: a clinical review","volume":"5","author":"Ross","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejphar.2013.03.042_bib55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(01)02504-6","article-title":"Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat","volume":"318","author":"Rossato","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2013.03.042_bib56","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/mds.21860","article-title":"Relevance of COX-2 gene expression in dementia with lewy bodies associated with Alzheimer pathology","volume":"23","author":"Saldana","year":"2008","journal-title":"Movement Disord."},{"key":"10.1016\/j.ejphar.2013.03.042_bib80","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1471-4159.1996.67010430.x","article-title":"Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice","volume":"67","author":"Schulz","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2013.03.042_bib57","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1172\/JCI0216390","article-title":"Cholesterol, lipid rafts, and disease","volume":"110","author":"Simons","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2013.03.042_bib58","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1083\/jcb.32.2.415","article-title":"An electron transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study","volume":"32","author":"Sottocasa","year":"1967","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib59","first-page":"424","article-title":"The molecular bases of Huntington's disease: a role played by oxidative stress","volume":"49","author":"Tasset","year":"2009","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pneurobio.2006.09.005","article-title":"Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?","volume":"80","author":"Valenza","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib61","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn1100","article-title":"Targeting programmed cell death in neurodegenerative diseases","volume":"4","author":"Vila","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2013.03.042_bib62","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1471-4159.2008.05604.x","article-title":"Mitochondrial alterations in Parkinson's disease: new clues","volume":"107","author":"Vila","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2013.03.042_bib63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.ATV.20.1.61","article-title":"Improvement of nitric oxide-dependent vasodilation by HMG-CoA reducatse inhibitors through attenuation of endothelial superoxide anion formation","volume":"20","author":"Wagner","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib64","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(04)16739-1","article-title":"Targeting energy metabolism in Huntington's disease","volume":"364","author":"Walker","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2013.03.042_bib65","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bbrc.2005.12.125","article-title":"The negative cell cycle regulator, Tob (transducer of ErbB-2), is involved in motor skill learning","volume":"340","author":"Wang","year":"2006","journal-title":"Biochem. Biophy. Res. Commun."},{"key":"10.1016\/j.ejphar.2013.03.042_bib66","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1124\/mol.59.3.646","article-title":"Inhibition of geranylation reduces angiotensin \u0399\u0399-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac 1 GTPase","volume":"59","author":"Wassmann","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.042_bib67","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanisms of lipid peroxide formation in animal tissues","volume":"99","author":"Wills","year":"1966","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2013.03.042_bib68","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1006\/exnr.1999.7283","article-title":"NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum","volume":"161","author":"Zeevalk","year":"2000","journal-title":"Exp. Neurol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913002604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913002604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T00:57:46Z","timestamp":1644713866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913002604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":69,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0014299913002604"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.03.042","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistical neuroprotection of rofecoxib and statins against malonic acid induced Huntington's disease like symptoms and related cognitive dysfunction in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}